Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
130 participants
INTERVENTIONAL
2025-05-15
2025-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Cold Dialysis in Combination With Intradialytic Exercise in Aspects Related to Quality of Life and Health
NCT03905551
Temperature and Bicarbonate: Hemodynamic Effects During Dialysis
NCT05052151
Dialysate Temperature in Peritoneal Dialysis
NCT04302649
Effect of Dialysate Temperature on Haemodynamic Stability and Haemodialysis Efficiency
NCT00221598
The Effect of Foot Bath on Comfort, Fatigue, and Dialysis Symptoms
NCT05759169
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Research Hypothesis
H1: Cold dialysis application reduces the level of post-dialysis fatigue.
METHOD
Research Design
This study was designed as a single group pre-test-post-test experimental design.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cold Dialysis
To be applied with cold dialysis
cold dialysis
Patients who meet the inclusion criteria will receive 3 sessions of cold dialysis treatment by reducing the dialysate temperature from 36.5°C to 36°C. Patients will receive this treatment for 1 week, i.e. 3 dialysis sessions. Each dialysis session will last 4 hours. During each dialysis session, the thermal comfort status of the patients will be evaluated by applying the Temperature Comfort Perception Scale at the beginning of dialysis, at the 1st, 2nd and 3rd hours of dialysis and at the end of dialysis. In addition, the day after each session, the patients will be called by phone and the Postdialysis Fatigue Scale will be re-administered and their fatigue levels will be evaluated.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cold dialysis
Patients who meet the inclusion criteria will receive 3 sessions of cold dialysis treatment by reducing the dialysate temperature from 36.5°C to 36°C. Patients will receive this treatment for 1 week, i.e. 3 dialysis sessions. Each dialysis session will last 4 hours. During each dialysis session, the thermal comfort status of the patients will be evaluated by applying the Temperature Comfort Perception Scale at the beginning of dialysis, at the 1st, 2nd and 3rd hours of dialysis and at the end of dialysis. In addition, the day after each session, the patients will be called by phone and the Postdialysis Fatigue Scale will be re-administered and their fatigue levels will be evaluated.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 and over
* Having been on hemodialysis for at least 6 months
* Having hemodialysis 3 times a week
* Having a high postdialysis fatigue score cut-off point compared to the mean
Exclusion Criteria
* Having a body temperature above 37.5°C
* Having serious cardiovascular diseases (e.g., uncontrolled hypertension, congestive heart failure)
* Having a history of acute complications during dialysis
* Having a history of severe hypotension
* Patients whose dialysis treatment was interrupted
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baskent University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gülay Turgay
assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gülay Turgay
Role: STUDY_DIRECTOR
Baskent Universitesi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baskent University
Ankara, Türkiye, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dialysis
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.